Change - Announcement of Appointment::Appointment of Independent Non-Executive Director

Issuer & Securities

Issuer/ Manager
OLAM INTERNATIONAL LIMITED
Securities
OLAM INTERNATIONAL LIMITED - SG1Q75923504 - O32
Stapled Security
No

Announcement Details

Announcement Title
Change - Announcement of Appointment
Date &Time of Broadcast
30-Aug-2019 17:25:23
Status
New
Announcement Sub Title
Appointment of Independent Non-Executive Director
Announcement Reference
SG190830OTHR4M7R
Submitted By (Co./ Ind. Name)
Michelle Tanya Kwek
Designation
Company Secretary
Description (Please provide a detailed description of the event in the box below)
Appointment of Dr. Ajai Puri as Independent Non-Executive Director

Additional Details

Date Of Appointment
01/09/2019
Name Of Person
Dr. Ajai Puri
Age
65
Country Of Principal Residence
United Kingdom
The Board's comments on this appointment (including rationale, selection criteria, and the search and nomination process)
The Governance and Nomination Committee (GNC) reviewed the proposed appointment of Dr. Ajai Puri as an Independent Non-Executive Director and took into consideration the feedback of the Board on its composition and diversity of experience. Consequent to the review by the GNC, the Board carried out its review and assessment of the experience, skillset, qualification and qualities of Dr. Ajai Puri. The Board also considered the existing composition of the Board, the size of the Board as well as the diversity of experience of the Board. Dr. Puri is considered by the Board as having possessed extensive business and industry experience that can complement the existing Board. The Board is satisfied that Dr. Puri will be able to contribute significantly to the Company.
Whether appointment is executive, and if so, the area of responsibility
Non-Executive
Job Title (e.g. Lead ID, AC Chairman, AC Member etc.)
Independent Non-Executive Director
Professional qualifications
MBA in Marketing, 1984
Crummer Business School, Rollins College, USA

PhD in Food Science, 1981
University of Maryland, USA
Any relationship (including immediate family relationships) with any existing director, existing executive officer, the issuer and/ or substantial shareholder of the listed issuer or any of its principal subsidiaries
No
Conflict of interests (including any competing business)
No
Working experience and occupation(s) during the past 10 years
Dr. Ajai Puri, from 1981 to 2003, was with The Coca-Cola Company where he held a variety of roles in Research and Development, Innovation, Consumer Marketing and General Management. When he left Coca-Cola in 2003, he was Senior Vice President - Science and Technology for Coca-Cola's non-carbonated juice business in North America. From 2003 to 2007, Dr. Puri was Executive Board Member and President - Research, Development and Product Integrity at Amsterdam-based Royal Numico N.V. He served as an Adviser to Mead Johnson Nutrition (2008-2010) and DSM N.V. (2008-2011). He was also a Non-Executive Director with Nutreco N.V. (2009-2015) and Barry Callebaut AG (2011-2014). Dr Puri is presently a Non-Executive Director with Firmenich S.A., Tate and Lyle PLC, Britannia Industries Ltd and the Global Alliance for Improved Nutrition (G.A.I.N.).
Undertaking submitted to the listed issuer in the form of Appendix 7.7 (Listing Rule 704(7)) Or Appendix 7H (Catalist Rule 704(6))
Yes
Shareholding interest in the listed issuer and its subsidiaries?
No
Other Principal Commitments* Including Directorships#
*"Principal Commitments" has the same meaning as defined in the Code
# These fields are not applicable for announcements of appointments pursuant to Listing Rule 704 (9) or Catalist Rule 704 (8).
Past (for the last 5 years)
Non-Executive Director, Firmenich S.A.
Non-Executive Director, Britannia Industries Ltd
Non-Executive Director, Tate and Lyle PLC
Non-Executive Director, Global Alliance for Improved Nutrition (G.A.I.N.)
Advisory Member, Jacobs Holding AG

Present
Non-Executive Director, Firmenich S.A.
Non-Executive Director, Britannia Industries Ltd
Non-Executive Director, Tate and Lyle PLC
Non-Executive Director, Global Alliance for Improved Nutrition (G.A.I.N.)
Advisory Member, Jacobs Holding AG
(a) Whether at any time during the last 10 years, an application or a petition under any bankruptcy law of any jurisdiction was filed against him or against a partnership of which he was a partner at the time when he was a partner or at any time within 2 years from the date he ceased to be a partner?
No
(b) Whether at any time during the last 10 years, an application or a petition under any law of any jurisdiction was filed against an entity (not being a partnership) of which he was a director or an equivalent person or a key executive, at the time when he was a director or an equivalent person or a key executive of that entity or at any time within 2 years from the date he ceased to be a director or an equivalent person or a key executive of that entity, for the winding up or dissolution of that entity or, where that entity is the trustee of a business trust, that business trust, on the ground of insolvency?
No
(c) Whether there is any unsatisfied judgment against him?
No
(d) Whether he has ever been convicted of any offence, in Singapore or elsewhere, involving fraud or dishonesty which is punishable with imprisonment, or has been the subject of any criminal proceedings (including any pending criminal proceedings of which he is aware) for such purpose?
No
(e) Whether he has ever been convicted of any offence, in Singapore or elsewhere, involving a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, or has been the subject of any criminal proceedings (including any pending criminal proceedings of which he is aware) for such breach?
No
(f) Whether at any time during the last 10 years, judgment has been entered against him in any civil proceedings in Singapore or elsewhere involving a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, or a finding of fraud, misrepresentation or dishonesty on his part, or he has been the subject of any civil proceedings (including any pending civil proceedings of which he is aware) involving an allegation of fraud, misrepresentation or dishonesty on his part?
No
(g) Whether he has ever been convicted in Singapore or elsewhere of any offence in connection with the formation or management of any entity or business trust?
No
(h) Whether he has ever been disqualified from acting as a director or an equivalent person of any entity (including the trustee of a business trust), or from taking part directly or indirectly in the management of any entity or business trust?
No
(i) Whether he has ever been the subject of any order, judgment or ruling of any court, tribunal or governmental body, permanently or temporarily enjoining him from engaging in any type of business practice or activity?
No
(j) Whether he has ever, to his knowledge, been concerned with the management or conduct, in Singapore or elsewhere, of the affairs of :-
(i) any corporation which has been investigated for a breach of any law or regulatory requirement governing corporations in Singapore or elsewhere; or
No
(ii) any entity (not being a corporation) which has been investigated for a breach of any law or regulatory requirement governing such entities in Singapore or elsewhere; or
No
(iii) any business trust which has been investigated for a breach of any law or regulatory requirement governing business trusts in Singapore or elsewhere; or
No
(iv) any entity or business trust which has been investigated for a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, in connection with any matter occurring or arising during that period when he was so concerned with the entity or business trust?
No
(k) Whether he has been the subject of any current or past investigation or disciplinary proceedings, or has been reprimanded or issued any warning, by the Monetary Authority of Singapore or any other regulatory authority, exchange, professional body or government agency, whether in Singapore or elsewhere?
No
Disclosure applicable to the appointment of Director only.
Any prior experience as a director of an issuer listed on the Exchange?
No
If no, please state if the director has attended or will be attending training on the roles and responsibilities of a director of a listed issuer as prescribed by the Exchange
No
Please provide details of relevant experience and the nominating committee's reasons for not requiring the director to undergo training as prescribed by the Exchange (if applicable)
Dr. Ajai Puri has had extensive professional experience including being Board Member of companies listed on various overseas exchange, namely, Nutreco BV listed on the Amsterdam Stock Exchange, Barry Callebaut AG listed on the SIX Swiss Exchange and Britannia Industries Ltd listed on the Bombay Stock Exchange and National Stock Exchange of India and Tate & Lyle PLC listed on the London Stock Exchange. The Governance and Nomination Committee found Dr. Puri's experience on the various overseas exchanges as relevant and comparable to the experience of a person who has served as a director of an issuer listed on the Singapore Exchange.

As part of the new director induction program, Dr. Puri will also be briefed on the local legal, regulatory and governance requirements as well as the duties of a director.